CD8A and cervical adenocarcinoma: Thus, in this study, we aimed to investigate whether the expression levels of PD-L1, PD-1, and CD8 can predict the prognosis of cervical adenocarcinoma patients and their response to immune-checkpoint inhibition therapy.